KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Enterprise Value: 2009-2024

Historic Enterprise Value for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $964.8 million.

  • Dynavax Technologies' Enterprise Value fell 25.75% to $516.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year increase of 2.22%. This contributed to the annual value of $964.8 million for FY2024, which is 9.38% down from last year.
  • As of FY2024, Dynavax Technologies' Enterprise Value stood at $964.8 million, which was down 9.38% from $1.1 billion recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Enterprise Value ranged from a high of $1.1 billion in FY2021 and a low of $325.2 million during FY2020.
  • Its 3-year average for Enterprise Value is $920.9 million, with a median of $964.8 million in 2024.
  • As far as peak fluctuations go, Dynavax Technologies' Enterprise Value skyrocketed by 251.06% in 2021, and later tumbled by 35.79% in 2022.
  • Over the past 5 years, Dynavax Technologies' Enterprise Value (Yearly) stood at $325.2 million in 2020, then soared by 251.06% to $1.1 billion in 2021, then slumped by 35.79% to $733.1 million in 2022, then soared by 45.24% to $1.1 billion in 2023, then fell by 9.38% to $964.8 million in 2024.